Fig. 1From: Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case reportLeft ventricular ejection fraction values in the treatment period. T: trastuzumab, D: docetaxel, VNR: vinorelbine, C: capecitabine, L: lapatinibBack to article page